Gastrointestinal Cancer News

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

Despite global declines in liver cancer mortality attributed to hepatitis B and C, liver cancer mortality rose sharply in the Americas, driven by an increase in nonalcoholic steatohepatitis, according to data published in Cell Metabolism.

Use of electronic medical record data alone led to overestimates of OS compared with survival curves generated using combined EMR and cancer registry data, according to study results published in JCO Clinical Cancer Informatics.

President Joe Biden today announced his intention to appoint Monica M. Bertagnolli, MD, FACS, FASCO, as NCI director.

A phase 3 trial of the PD-1 inhibitor tislelizumab met its primary endpoint of noninferior OS compared with sorafenib as first-line treatment for adults with unresectable hepatocellular carcinoma, according to the agent’s manufacturer.

Patients with cirrhosis who have hepatitis B virus infection and a history of heavy alcohol use are at higher risk for hepatocellular carcinoma and mortality, according to a study published in JAMA Network Open.

Individuals with Lynch syndrome who took resistant starch supplements for at least 2 years developed significantly fewer non-colorectal cancers, results of a 10-year follow-up study in Cancer Prevention Research showed.

Men appeared to have a higher risk for cancer than women at most shared anatomic sites, according to study results published in Cancer.

Hepatocellular carcinoma surveillance was underutilized in more than 80% of patients with cirrhosis, with lack of clinician orders and lack of patient adherence cited as common screening barriers, according to a study in JAMA Network Open.

A new voluntary oncology payment model the Biden administration announced earlier this summer has been met with support, as well as concerns, from several cancer organizations.